Related Experiment Video
Updated: Oct 8, 2025
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
The Role of miRNA in Ovarian Cancer: an Overview
Lihui Zhao1, Xiaolei Liang1, Liyan Wang1
1Key Laboratory for Reproductive Medicine and Embryo of Gansu, First Affiliated Hospital, Lanzhou University, No.1, Donggangxi Rd, Chengguan District, Lanzhou City, Gansu, 730000, People's Republic of China.
Abstract:
Ovarian cancer (OC) is a highly malignant disease that seriously threatens women's health and poses challenges for clinicians. MicroRNAs (miRNAs) have recently been intensively studied in the field of oncology due to their regulatory roles in gene expressions through RNA degradation and/or translation inhibition. This review summarizes the current studies on miRNAs in OC and introduces the latest updates of miRNAs in the early screening, treatment, and prognostic prediction of OC, thereby demonstrating the clinical significance of miRNAs in OC. Further exploration on potential targets of miRNAs in OC may provide new insights on optimizing the diagnosis and treatment of OC. MiRNAs are important driving factors for the progression of OC and the dysregulation of miRNAs can serve as biomarkers in the diagnosis, treatment and prognosis of OC. Therefore, miRNAs are potential biological targets for early screening, targeted therapy, drug resistance monitoring, and prognosis improvement in malignancies such as OC.
Insights
MicroRNAs (miRNAs) are crucial in ovarian cancer (OC) progression. Dysregulated miRNAs show potential as biomarkers for early screening, treatment, and prognosis in OC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ovarian cancer (OC) is a significant threat to women's health, presenting clinical challenges.
- MicroRNAs (miRNAs) are key regulators of gene expression, impacting oncology research.
- miRNAs function via RNA degradation and/or translation inhibition.
Purpose of the Study:
- To review current research on microRNAs (miRNAs) in ovarian cancer (OC).
- To present the latest updates on miRNAs for early screening, treatment, and prognostic prediction in OC.
- To highlight the clinical significance and potential of miRNAs in OC management.
Main Methods:
- Comprehensive literature review of studies on miRNAs in ovarian cancer.
- Analysis of current research findings on miRNA roles in OC development and progression.
- Synthesis of data regarding miRNA applications in OC diagnosis and therapy.
Main Results:
- MicroRNAs (miRNAs) are implicated as driving factors in ovarian cancer (OC) progression.
- Dysregulated miRNAs can serve as valuable biomarkers for OC diagnosis, treatment response, and prognosis.
- miRNAs demonstrate potential for early detection and targeted therapeutic strategies in OC.
Conclusions:
- MicroRNAs (miRNAs) are integral to ovarian cancer (OC) pathogenesis and progression.
- Further research into miRNA targets can optimize OC diagnosis and treatment strategies.
- miRNAs offer promising avenues for early screening, targeted therapy, and improved prognosis in OC.
Related Concept Videos
01:22MicroRNAs
02:15Experimental RNAi
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...